MAGE-C2 antigenic peptides and uses thereof

MAGE-C2 antigenic peptides and uses thereof

2 This invention relates to isolated peptides derived from MAGE-C2, nucleic acid molecules that encode MAGE-C2 and the isolated peptides derived from MAGE-C2, expression vectors comprising the nucleic acid molecules, host cells transformed or transfected with the nucleic acid molecules or the expres...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ma, Wenbin, Van Den Eynde, Benoit, Boon-Falleur, Thierry, Germeau, Catherine, Coulie, Pierre, Vigneron, Nathalie
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Ma, Wenbin
Van Den Eynde, Benoit
Boon-Falleur, Thierry
Germeau, Catherine
Coulie, Pierre
Vigneron, Nathalie
description 2 This invention relates to isolated peptides derived from MAGE-C2, nucleic acid molecules that encode MAGE-C2 and the isolated peptides derived from MAGE-C2, expression vectors comprising the nucleic acid molecules, host cells transformed or transfected with the nucleic acid molecules or the expression vectors, and to tetramers comprising the peptides, HLA molecules, ∃microglobulin and a first and second binding partner. This invention also relates to methods for using the peptides, nucleic acid molecules, expression vectors, tetramers and complexes of this invention as well as to cytolytic T cells which recognize the peptides in complex with an HLA molecule.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_08143011</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>08143011</sourcerecordid><originalsourceid>FETCH-uspatents_grants_081430113</originalsourceid><addsrcrecordid>eNrjZND2dXR31XU2UkjMK8lMT83LTFYoSC0oyUxJLQYKpSiUFgMZJRmpRan5aTwMrGmJOcWpvFCam0HBzTXE2UO3tLggsSQ1r6Q4Pr0oEUQZWBiaGBsYGhoToQQAuckpMA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MAGE-C2 antigenic peptides and uses thereof</title><source>USPTO Issued Patents</source><creator>Ma, Wenbin ; Van Den Eynde, Benoit ; Boon-Falleur, Thierry ; Germeau, Catherine ; Coulie, Pierre ; Vigneron, Nathalie</creator><creatorcontrib>Ma, Wenbin ; Van Den Eynde, Benoit ; Boon-Falleur, Thierry ; Germeau, Catherine ; Coulie, Pierre ; Vigneron, Nathalie ; Ludwig Institute for Cancer Research</creatorcontrib><description>2 This invention relates to isolated peptides derived from MAGE-C2, nucleic acid molecules that encode MAGE-C2 and the isolated peptides derived from MAGE-C2, expression vectors comprising the nucleic acid molecules, host cells transformed or transfected with the nucleic acid molecules or the expression vectors, and to tetramers comprising the peptides, HLA molecules, ∃microglobulin and a first and second binding partner. This invention also relates to methods for using the peptides, nucleic acid molecules, expression vectors, tetramers and complexes of this invention as well as to cytolytic T cells which recognize the peptides in complex with an HLA molecule.</description><language>eng</language><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8143011$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64012</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8143011$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Ma, Wenbin</creatorcontrib><creatorcontrib>Van Den Eynde, Benoit</creatorcontrib><creatorcontrib>Boon-Falleur, Thierry</creatorcontrib><creatorcontrib>Germeau, Catherine</creatorcontrib><creatorcontrib>Coulie, Pierre</creatorcontrib><creatorcontrib>Vigneron, Nathalie</creatorcontrib><creatorcontrib>Ludwig Institute for Cancer Research</creatorcontrib><title>MAGE-C2 antigenic peptides and uses thereof</title><description>2 This invention relates to isolated peptides derived from MAGE-C2, nucleic acid molecules that encode MAGE-C2 and the isolated peptides derived from MAGE-C2, expression vectors comprising the nucleic acid molecules, host cells transformed or transfected with the nucleic acid molecules or the expression vectors, and to tetramers comprising the peptides, HLA molecules, ∃microglobulin and a first and second binding partner. This invention also relates to methods for using the peptides, nucleic acid molecules, expression vectors, tetramers and complexes of this invention as well as to cytolytic T cells which recognize the peptides in complex with an HLA molecule.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZND2dXR31XU2UkjMK8lMT83LTFYoSC0oyUxJLQYKpSiUFgMZJRmpRan5aTwMrGmJOcWpvFCam0HBzTXE2UO3tLggsSQ1r6Q4Pr0oEUQZWBiaGBsYGhoToQQAuckpMA</recordid><startdate>20120327</startdate><enddate>20120327</enddate><creator>Ma, Wenbin</creator><creator>Van Den Eynde, Benoit</creator><creator>Boon-Falleur, Thierry</creator><creator>Germeau, Catherine</creator><creator>Coulie, Pierre</creator><creator>Vigneron, Nathalie</creator><scope>EFH</scope></search><sort><creationdate>20120327</creationdate><title>MAGE-C2 antigenic peptides and uses thereof</title><author>Ma, Wenbin ; Van Den Eynde, Benoit ; Boon-Falleur, Thierry ; Germeau, Catherine ; Coulie, Pierre ; Vigneron, Nathalie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_081430113</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Ma, Wenbin</creatorcontrib><creatorcontrib>Van Den Eynde, Benoit</creatorcontrib><creatorcontrib>Boon-Falleur, Thierry</creatorcontrib><creatorcontrib>Germeau, Catherine</creatorcontrib><creatorcontrib>Coulie, Pierre</creatorcontrib><creatorcontrib>Vigneron, Nathalie</creatorcontrib><creatorcontrib>Ludwig Institute for Cancer Research</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Ma, Wenbin</au><au>Van Den Eynde, Benoit</au><au>Boon-Falleur, Thierry</au><au>Germeau, Catherine</au><au>Coulie, Pierre</au><au>Vigneron, Nathalie</au><aucorp>Ludwig Institute for Cancer Research</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MAGE-C2 antigenic peptides and uses thereof</title><date>2012-03-27</date><risdate>2012</risdate><abstract>2 This invention relates to isolated peptides derived from MAGE-C2, nucleic acid molecules that encode MAGE-C2 and the isolated peptides derived from MAGE-C2, expression vectors comprising the nucleic acid molecules, host cells transformed or transfected with the nucleic acid molecules or the expression vectors, and to tetramers comprising the peptides, HLA molecules, ∃microglobulin and a first and second binding partner. This invention also relates to methods for using the peptides, nucleic acid molecules, expression vectors, tetramers and complexes of this invention as well as to cytolytic T cells which recognize the peptides in complex with an HLA molecule.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_08143011
source USPTO Issued Patents
title MAGE-C2 antigenic peptides and uses thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T09%3A38%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Ma,%20Wenbin&rft.aucorp=Ludwig%20Institute%20for%20Cancer%20Research&rft.date=2012-03-27&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E08143011%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true